Cargando…
Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children
BACKGROUND: We aimed to show the non-inferiority of home fortification with a daily dose of 3 mg iron in the form of iron as ferric sodium ethylenediaminetetraacetate (NaFeEDTA) compared with 12.5 mg iron as encapsulated ferrous fumarate in Kenyan children aged 12–36 months. In addition, we updated...
Autores principales: | Teshome, Emily M., Andang’o, Pauline E. A., Osoti, Victor, Terwel, Sofie R., Otieno, Walter, Demir, Ayşe Y., Prentice, Andrew M., Verhoef, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408380/ https://www.ncbi.nlm.nih.gov/pubmed/28449690 http://dx.doi.org/10.1186/s12916-017-0839-z |
Ejemplares similares
-
Comparison of home fortification with two iron formulations among Kenyan children: Rationale and design of a placebo-controlled non-inferiority trial
por: Teshome, Emily M., et al.
Publicado: (2017) -
Diagnostic utility of zinc protoporphyrin to detect iron deficiency in Kenyan preschool children: a community-based survey
por: Teshome, Emily M., et al.
Publicado: (2017) -
Adherence to home fortification with micronutrient powders in Kenyan pre-school children: self-reporting and sachet counts compared to an electronic monitoring device
por: Teshome, Emily M., et al.
Publicado: (2018) -
Antenatal iron supplementation, FGF23, and bone metabolism in Kenyan women and their offspring: secondary analysis of a randomized controlled trial
por: Braithwaite, Vickie S, et al.
Publicado: (2021) -
SUN-359 Antenatal Oral Iron Supplementation, FGF23 and Bone Metabolism in Kenyan Women and Their Offspring: A Randomised Controlled Trial
por: Braithwaite, Vickie S, et al.
Publicado: (2020)